Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global and United States Diabetic Lancets Market Report & Forecast 2024-2030

Global and United States Diabetic Lancets Market Report & Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-10-23

Pages: 143 Pages

Report ld: 3351870

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Diabetic Lancets Market Size(US$)

CAGR 2024-2030

4.3%

Market Size,2030

USD 1,543

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 1,201 million

Market Forecast in 2030(Value)

US$ 1,543 million

CAGR

4.3%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

A diabetic lancet is a small, sharp device used to prick the skin, typically the fingertip, to obtain a drop of blood for blood glucose testing. It is a key tool in diabetes management, allowing individuals with diabetes to regularly monitor their blood sugar levels. Lancets are often used with blood glucose meters and are designed to minimize pain and discomfort during testing. They are available in different sizes and needle thicknesses to suit various skin types and sensitivity levels.

The global Diabetic Lancets revenue was US$ 1153 million in 2023 and is forecast to a readjusted size of US$ 1543 million by 2030 with a CAGR of 4.3% during the review period (2024-2030).

In United States the Diabetic Lancets revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Diabetic Lancets market, also covers the segmentation data of other regions in regional level and county level.

Market Drivers:

Rising prevalence of diabetes: The global surge in diabetes cases, fueled by lifestyle changes, poor diets, and increasing obesity, has led to higher demand for blood sugar monitoring devices, including lancets.

Increased awareness about diabetes management: Governments and healthcare organizations are focusing on awareness campaigns about the importance of regular blood sugar monitoring, which boosts demand for self-monitoring devices and lancets.

Technological advancements: Continuous innovations in lancet design, such as painless, ultra-thin, and easy-to-use lancets, are attracting consumers who prefer comfortable and convenient blood sugar testing methods.

Aging population: Older adults are more prone to diabetes and require frequent blood sugar monitoring, thereby increasing the demand for lancets in healthcare settings.

Home healthcare trend: The growing preference for home-based healthcare and self-monitoring tools has led to a rise in the use of personal blood glucose monitoring systems, including lancets.

Increase in health expenditures: Higher healthcare spending by both individuals and governments is propelling the growth of diabetes-related products, especially in developing countries.

Market Challenges:

Risk of infections: Improper use of lancets or reusing them can lead to infections, which may deter some individuals from using these devices consistently.

Cost pressures: Lancet devices are often seen as a recurring expense for diabetes patients, which can be a financial burden, especially in low-income countries. This may limit market growth among economically disadvantaged populations.

Availability of alternatives: The development of non-invasive blood glucose monitoring systems (e.g., sensor-based or continuous glucose monitors) is a potential threat to lancet usage, as they reduce the need for frequent finger-pricking.

Regulatory hurdles: Stringent regulations and the need for approvals from healthcare authorities can slow down the launch of new and improved lancet technologies, limiting the pace of market growth.

Environmental concerns: Lancets are generally single-use items, and their disposal raises concerns about medical waste and environmental impact, which may affect their adoption if eco-friendliness becomes a critical factor for consumers or policymakers.

The classification of Lancets includes Ordinary Lancets and Safety Lancets. In 2023, Ordinary Lancets accounted for a share of 61.81% in the global Lancets market. With several hospitals and healthcare facilities converting to safety lancets, this market share is poised for declined. Americas is the largest consumption place, with a consumption market share nearly 40.77% in 2022. Following Americas, Europe is the second largest consumption place with the consumption market share of 30.34%.

Diabetic Lancets market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Diabetic Lancets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Diabetic Lancets market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

MARKET SEGMENTATION

By Company

Roche
Lifescan
BD
Ascensia
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Cardinal Health
ICU Medical
Sarstedt
Sinocare
Yicheng
Yuwell

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Safety Lancets
Ordinary Lancets

Segment by Application

Hospital
Homecare
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces Diabetic Lancets definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Diabetic Lancets companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of Diabetic Lancets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Lancets sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: research findings and conclusion

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Diabetic Lancets Product Introduction

1.2 Global Diabetic Lancets Outlook 2019 VS 2023 VS 2030

1.2.1 Global Diabetic Lancets Sales in US$ Million for the Year 2019-2030

1.2.2 Global Diabetic Lancets Sales in Volume for the Year 2019-2030

1.3 United States Diabetic Lancets Outlook 2019 VS 2023 VS 2030

1.3.1 United States Diabetic Lancets Sales in US$ Million for the Year 2019-2030

1.3.2 United States Diabetic Lancets Sales in Volume for the Year 2019-2030

1.4 Diabetic Lancets Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.4.1 The Market Share of United States Diabetic Lancets in Global, 2019 VS 2023 VS 2030

1.4.2 The Growth Rate of Diabetic Lancets Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.5 Diabetic Lancets Market Dynamics

1.5.1 Diabetic Lancets Industry Trends

1.5.2 Diabetic Lancets Market Drivers

1.5.3 Diabetic Lancets Market Challenges

1.5.4 Diabetic Lancets Market Restraints

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Diabetic Lancets by Type

2.1 Diabetic Lancets Market by Type

2.1.1 Safety Lancets

2.1.2 Ordinary Lancets

2.2 Global Diabetic Lancets Market Size by Type

2.2.1 Global Diabetic Lancets Sales in Value, by Type (2019, 2023 & 2030)

2.2.2 Global Diabetic Lancets Sales in Volume, by Type (2019, 2023 & 2030)

2.2.3 Global Diabetic Lancets Average Selling Price (ASP) by Type (2019, 2023 & 2030)

2.3 United States Diabetic Lancets Market Size by Type

2.3.1 United States Diabetic Lancets Sales in Value, by Type (2019, 2023 & 2030)

2.3.2 United States Diabetic Lancets Sales in Volume, by Type (2019, 2023 & 2030)

2.3.3 United States Diabetic Lancets Average Selling Price (ASP) by Type (2019, 2023 & 2030)

3 Diabetic Lancets by Application

3.1 Diabetic Lancets Market by Application

3.1.1 Hospital

3.1.2 Homecare

3.1.3 Other

3.2 Global Diabetic Lancets Market Size by Application

3.2.1 Global Diabetic Lancets Sales in Value, by Application (2019, 2023 & 2030)

3.2.2 Global Diabetic Lancets Sales in Volume, by Application (2019, 2023 & 2030)

3.2.3 Global Diabetic Lancets Average Selling Price (ASP) by Application (2019, 2023 & 2030)

3.3 United States Diabetic Lancets Market Size by Application

3.3.1 United States Diabetic Lancets Sales in Value, by Application (2019, 2023 & 2030)

3.3.2 United States Diabetic Lancets Sales in Volume, by Application (2019, 2023 & 2030)

3.3.3 United States Diabetic Lancets Average Selling Price (ASP) by Application (2019, 2023 & 2030)

4 Global Diabetic Lancets Competitor Landscape by Company

4.1 Global Diabetic Lancets Market Size by Company

4.1.1 Global Key Manufacturers of Diabetic Lancets, Ranked by Revenue (2023)

4.1.2 Global Diabetic Lancets Revenue by Manufacturer (2019-2024)

4.1.3 Global Diabetic Lancets Sales by Manufacturer (2019-2024)

4.1.4 Global Diabetic Lancets Price by Manufacturer (2019-2024)

4.2 Global Diabetic Lancets Concentration Ratio (CR)

4.2.1 Diabetic Lancets Market Concentration Ratio (CR) (2019-2024)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Diabetic Lancets in 2023

4.2.3 Global Diabetic Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Diabetic Lancets, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Diabetic Lancets, Product Offered and Application

4.5 Global Key Manufacturers of Diabetic Lancets, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 United States Diabetic Lancets Market Size by Company

4.7.1 Key Players of Diabetic Lancets in United States, Ranked by Revenue (2023)

4.7.2 United States Diabetic Lancets Revenue by Players (2019-2024)

4.7.3 United States Diabetic Lancets Sales by Players (2019-2024)

5 Global Diabetic Lancets Market Size by Region

5.1 Global Diabetic Lancets Market Size by Region: 2019 VS 2023 VS 2030

5.2 Global Diabetic Lancets Market Size in Volume by Region (2019-2030)

5.2.1 Global Diabetic Lancets Sales in Volume by Region: 2019-2024

5.2.2 Global Diabetic Lancets Sales in Volume Forecast by Region (2025-2030)

5.3 Global Diabetic Lancets Market Size in Value by Region (2019-2030)

5.3.1 Global Diabetic Lancets Sales in Value by Region: 2019-2024

5.3.2 Global Diabetic Lancets Sales in Value by Region: 2025-2030

6 Americas

6.1 Americas Diabetic Lancets Market Size YoY Growth 2019-2030

6.2 Americas Diabetic Lancets Sales in Volume, by Type (2019, 2023 & 2030)

6.3 Americas Diabetic Lancets Sales in Volume, by Application (2019, 2023 & 2030)

6.4 Americas Diabetic Lancets Market Facts & Figures by Country (2019, 2023 & 2030)

6.4.1 Americas Diabetic Lancets Sales in Value by Country (2019, 2023 & 2030)

6.4.2 Americas Diabetic Lancets Sales in Volume by Country (2019, 2023 & 2030)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Diabetic Lancets Market Size YoY Growth 2019-2030

7.2 EMEA Diabetic Lancets Sales in Volume, by Type (2019, 2023 & 2030)

7.3 EMEA Diabetic Lancets Sales in Volume, by Application (2019, 2023 & 2030)

7.4 EMEA Diabetic Lancets Market Facts & Figures by Country (2019, 2023 & 2030)

7.4.1 EMEA Diabetic Lancets Sales in Value by Country (2019, 2023 & 2030)

7.4.2 EMEA Diabetic Lancets Sales in Volume by Country (2019, 2023 & 2030)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Diabetic Lancets Market Size YoY Growth 2019-2030

8.2 China Diabetic Lancets Sales in Volume, by Type (2019, 2023 & 2030)

8.3 China Diabetic Lancets Sales in Volume, by Application (2019, 2023 & 2030)

9 APAC

9.1 APAC Diabetic Lancets Market Size YoY Growth 2019-2030

9.2 APAC Diabetic Lancets Sales in Volume, by Type (2019, 2023 & 2030)

9.3 APAC Diabetic Lancets Sales in Volume, by Application (2019, 2023 & 2030)

9.4 APAC Diabetic Lancets Market Facts & Figures by Country (2019, 2023 & 2030)

9.4.1 APAC Diabetic Lancets Sales in Value by Country (2019, 2023 & 2030)

9.4.2 APAC Diabetic Lancets Sales in Volume by Country (2019, 2023 & 2030)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Roche

10.1.1 Roche Company Information

10.1.2 Roche Description and Business Overview

10.1.3 Roche Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.1.4 Roche Diabetic Lancets Products Offered

10.1.5 Roche Recent Development

10.2 Lifescan

10.2.1 Lifescan Company Information

10.2.2 Lifescan Description and Business Overview

10.2.3 Lifescan Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.2.4 Lifescan Diabetic Lancets Products Offered

10.2.5 Lifescan Recent Development

10.3 BD

10.3.1 BD Company Information

10.3.2 BD Description and Business Overview

10.3.3 BD Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.3.4 BD Diabetic Lancets Products Offered

10.3.5 BD Recent Development

10.4 Ascensia

10.4.1 Ascensia Company Information

10.4.2 Ascensia Description and Business Overview

10.4.3 Ascensia Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.4.4 Ascensia Diabetic Lancets Products Offered

10.4.5 Ascensia Recent Development

10.5 Abbott

10.5.1 Abbott Company Information

10.5.2 Abbott Description and Business Overview

10.5.3 Abbott Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.5.4 Abbott Diabetic Lancets Products Offered

10.5.5 Abbott Recent Development

10.6 B. Braun

10.6.1 B. Braun Company Information

10.6.2 B. Braun Description and Business Overview

10.6.3 B. Braun Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.6.4 B. Braun Diabetic Lancets Products Offered

10.6.5 B. Braun Recent Development

10.7 ARKRAY

10.7.1 ARKRAY Company Information

10.7.2 ARKRAY Description and Business Overview

10.7.3 ARKRAY Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.7.4 ARKRAY Diabetic Lancets Products Offered

10.7.5 ARKRAY Recent Development

10.8 Terumo

10.8.1 Terumo Company Information

10.8.2 Terumo Description and Business Overview

10.8.3 Terumo Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.8.4 Terumo Diabetic Lancets Products Offered

10.8.5 Terumo Recent Development

10.9 I-SENS

10.9.1 I-SENS Company Information

10.9.2 I-SENS Description and Business Overview

10.9.3 I-SENS Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.9.4 I-SENS Diabetic Lancets Products Offered

10.9.5 I-SENS Recent Development

10.10 Nipro

10.10.1 Nipro Company Information

10.10.2 Nipro Description and Business Overview

10.10.3 Nipro Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.10.4 Nipro Diabetic Lancets Products Offered

10.10.5 Nipro Recent Development

10.11 Cardinal Health

10.11.1 Cardinal Health Company Information

10.11.2 Cardinal Health Description and Business Overview

10.11.3 Cardinal Health Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.11.4 Cardinal Health Diabetic Lancets Products Offered

10.11.5 Cardinal Health Recent Development

10.12 ICU Medical

10.12.1 ICU Medical Company Information

10.12.2 ICU Medical Description and Business Overview

10.12.3 ICU Medical Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.12.4 ICU Medical Diabetic Lancets Products Offered

10.12.5 ICU Medical Recent Development

10.13 Sarstedt

10.13.1 Sarstedt Company Information

10.13.2 Sarstedt Description and Business Overview

10.13.3 Sarstedt Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.13.4 Sarstedt Diabetic Lancets Products Offered

10.13.5 Sarstedt Recent Development

10.14 Sinocare

10.14.1 Sinocare Company Information

10.14.2 Sinocare Description and Business Overview

10.14.3 Sinocare Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.14.4 Sinocare Diabetic Lancets Products Offered

10.14.5 Sinocare Recent Development

10.15 Yicheng

10.15.1 Yicheng Company Information

10.15.2 Yicheng Description and Business Overview

10.15.3 Yicheng Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.15.4 Yicheng Diabetic Lancets Products Offered

10.15.5 Yicheng Recent Development

10.16 Yuwell

10.16.1 Yuwell Company Information

10.16.2 Yuwell Description and Business Overview

10.16.3 Yuwell Diabetic Lancets Sales, Revenue and Gross Margin (2019-2024)

10.16.4 Yuwell Diabetic Lancets Products Offered

10.16.5 Yuwell Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Diabetic Lancets Industry Chain Analysis

11.2 Diabetic Lancets Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Diabetic Lancets Production Mode & Process

11.4 Diabetic Lancets Sales and Marketing

11.4.1 Diabetic Lancets Sales Channels

11.4.2 Diabetic Lancets Distributors

11.5 Diabetic Lancets Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Diabetic Lancets CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030

Table 2. Diabetic Lancets Market Trends

Table 3. Diabetic Lancets Market Drivers

Table 4. Diabetic Lancets Market Challenges

Table 5. Diabetic Lancets Market Restraints

Table 6. Global Diabetic Lancets Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. United States Diabetic Lancets Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Diabetic Lancets Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. United States Diabetic Lancets Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Key Manufacturers of Diabetic Lancets, Ranked by Revenue (2023) & (US$ Million)

Table 11. Global Diabetic Lancets Revenue by Manufacturer, (US$ Million) & (2019-2024)

Table 12. Global Diabetic Lancets Revenue Share by Manufacturer, 2019-2024

Table 13. Global Diabetic Lancets Sales by Manufacturer, (K Units), 2019-2024

Table 14. Global Diabetic Lancets Sales Share by Manufacturer, 2019-2024

Table 15. Global Diabetic Lancets Price by Manufacturer (2019-2024) & (US$/Unit)

Table 16. Global Diabetic Lancets Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Diabetic Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Lancets as of 2023)

Table 18. Global Key Manufacturers of Diabetic Lancets, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Diabetic Lancets, Product Offered and Application

Table 20. Global Key Manufacturers of Diabetic Lancets, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Diabetic Lancets in United States, Ranked by Revenue (2023) & (US$ million)

Table 23. United States Diabetic Lancets Revenue by Players, (US$ Million) & (2019-2024)

Table 24. United States Diabetic Lancets Revenue Share by Players, (2019-2024)

Table 25. United States Diabetic Lancets Sales by Players, (K Units) & (2019-2024)

Table 26. United States Diabetic Lancets Sales Share by Players, (2019-2024)

Table 27. Global Diabetic Lancets Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 28. Global Diabetic Lancets Sales in Volume by Region (2019-2024) & (K Units)

Table 29. Global Diabetic Lancets Sales in Volume Forecast by Region (2025-2030) & (K Units)

Table 30. Global Diabetic Lancets Sales in Value by Region (2019-2024) & (US$ Million)

Table 31. Global Diabetic Lancets Sales in Value Forecast by Region (2025-2030) & (US$ Million)

Table 32. Americas Diabetic Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. Americas Diabetic Lancets Sales in Value by Country (2019-2024) & (US$ Million)

Table 34. Americas Diabetic Lancets Sales in Value by Country (2025-2030) & (US$ Million)

Table 35. Americas Diabetic Lancets Sales in Volume by Country (2019-2024) & (K Units)

Table 36. Americas Diabetic Lancets Sales in Volume by Country (2025-2030) & (K Units)

Table 37. EMEA Diabetic Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. EMEA Diabetic Lancets Sales in Value by Country (2019-2024) & (US$ Million)

Table 39. EMEA Diabetic Lancets Sales in Value by Country (2025-2030) & (US$ Million)

Table 40. EMEA Diabetic Lancets Sales in Volume by Country (2019-2024) & (K Units)

Table 41. EMEA Diabetic Lancets Sales in Volume by Country (2025-2030) & (K Units)

Table 42. APAC Diabetic Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. APAC Diabetic Lancets Sales in Value by Country (2019-2024) & (US$ Million)

Table 44. APAC Diabetic Lancets Sales in Value by Country (2025-2030) & (US$ Million)

Table 45. APAC Diabetic Lancets Sales in Volume by Country (2019-2024) & (K Units)

Table 46. APAC Diabetic Lancets Sales in Volume by Country (2025-2030) & (K Units)

Table 47. Roche Company Information

Table 48. Roche Description and Business Overview

Table 49. Roche Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 50. Roche Diabetic Lancets Product

Table 51. Roche Recent Development

Table 52. Lifescan Company Information

Table 53. Lifescan Description and Business Overview

Table 54. Lifescan Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 55. Lifescan Diabetic Lancets Product

Table 56. Lifescan Recent Development

Table 57. BD Company Information

Table 58. BD Description and Business Overview

Table 59. BD Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. BD Diabetic Lancets Product

Table 61. BD Recent Development

Table 62. Ascensia Company Information

Table 63. Ascensia Description and Business Overview

Table 64. Ascensia Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Ascensia Diabetic Lancets Product

Table 66. Ascensia Recent Development

Table 67. Abbott Company Information

Table 68. Abbott Description and Business Overview

Table 69. Abbott Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Abbott Diabetic Lancets Product

Table 71. Abbott Recent Development

Table 72. B. Braun Company Information

Table 73. B. Braun Description and Business Overview

Table 74. B. Braun Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. B. Braun Diabetic Lancets Product

Table 76. B. Braun Recent Development

Table 77. ARKRAY Company Information

Table 78. ARKRAY Description and Business Overview

Table 79. ARKRAY Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. ARKRAY Diabetic Lancets Product

Table 81. ARKRAY Recent Development

Table 82. Terumo Company Information

Table 83. Terumo Description and Business Overview

Table 84. Terumo Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Terumo Diabetic Lancets Product

Table 86. Terumo Recent Development

Table 87. I-SENS Company Information

Table 88. I-SENS Description and Business Overview

Table 89. I-SENS Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. I-SENS Diabetic Lancets Product

Table 91. I-SENS Recent Development

Table 92. Nipro Company Information

Table 93. Nipro Description and Business Overview

Table 94. Nipro Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Nipro Diabetic Lancets Product

Table 96. Nipro Recent Development

Table 97. Cardinal Health Company Information

Table 98. Cardinal Health Description and Business Overview

Table 99. Cardinal Health Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Cardinal Health Diabetic Lancets Product

Table 101. Cardinal Health Recent Development

Table 102. ICU Medical Company Information

Table 103. ICU Medical Description and Business Overview

Table 104. ICU Medical Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. ICU Medical Diabetic Lancets Product

Table 106. ICU Medical Recent Development

Table 107. Sarstedt Company Information

Table 108. Sarstedt Description and Business Overview

Table 109. Sarstedt Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Sarstedt Diabetic Lancets Product

Table 111. Sarstedt Recent Development

Table 112. Sinocare Company Information

Table 113. Sinocare Description and Business Overview

Table 114. Sinocare Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Sinocare Diabetic Lancets Product

Table 116. Sinocare Recent Development

Table 117. Yicheng Company Information

Table 118. Yicheng Description and Business Overview

Table 119. Yicheng Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Yicheng Diabetic Lancets Product

Table 121. Yicheng Recent Development

Table 122. Yuwell Company Information

Table 123. Yuwell Description and Business Overview

Table 124. Yuwell Diabetic Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Yuwell Diabetic Lancets Product

Table 126. Yuwell Recent Development

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Diabetic Lancets Distributors List

Table 130. Diabetic Lancets Customers List

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Diabetic Lancets Product Picture

Figure 2. Global Diabetic Lancets Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 3. Global Diabetic Lancets Market Size 2019-2030 (US$ Million)

Figure 4. Global Diabetic Lancets Sales 2019-2030 (K Units)

Figure 5. United States Diabetic Lancets Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 6. United States Diabetic Lancets Market Size 2019-2030 (US$ Million)

Figure 7. United States Diabetic Lancets Sales 2019-2030 (K Units)

Figure 8. United States Diabetic Lancets Market Share in Global, in Value (US$ Million) 2019-2030

Figure 9. United States Diabetic Lancets Market Share in Global, in Volume (K Units) 2019-2030

Figure 10. Diabetic Lancets Report Years Considered

Figure 11. Product Picture of Safety Lancets

Figure 12. Product Picture of Ordinary Lancets

Figure 13. Global Diabetic Lancets Market Share by Type in 2023 & 2030

Figure 14. Global Diabetic Lancets Sales in Value by Type (2019-2030) & (US$ Million)

Figure 15. Global Diabetic Lancets Sales Market Share in Value by Type (2019-2030)

Figure 16. Global Diabetic Lancets Sales by Type (2019-2030) & (K Units)

Figure 17. Global Diabetic Lancets Sales Market Share in Volume by Type (2019-2030)

Figure 18. Global Diabetic Lancets Price by Type (2019-2030) & (US$/Unit)

Figure 19. United States Diabetic Lancets Market Share by Type in 2023 & 2030

Figure 20. United States Diabetic Lancets Sales in Value by Type (2019-2030) & (US$ Million)

Figure 21. United States Diabetic Lancets Sales Market Share in Value by Type (2019-2030)

Figure 22. United States Diabetic Lancets Sales by Type (2019-2030) & (K Units)

Figure 23. United States Diabetic Lancets Sales Market Share in Volume by Type (2019-2030)

Figure 24. United States Diabetic Lancets Price by Type (2019-2030) & (US$/Unit)

Figure 25. Product Picture of Hospital

Figure 26. Product Picture of Homecare

Figure 27. Product Picture of Other

Figure 28. Global Diabetic Lancets Market Share by Application in 2023 & 2030

Figure 29. Global Diabetic Lancets Sales in Value by Application (2019-2030) & (US$ Million)

Figure 30. Global Diabetic Lancets Sales Market Share in Value by Application (2019-2030)

Figure 31. Global Diabetic Lancets Sales by Application (2019-2030) & (K Units)

Figure 32. Global Diabetic Lancets Sales Market Share in Volume by Application (2019-2030)

Figure 33. Global Diabetic Lancets Price by Application (2019-2030) & (US$/Unit)

Figure 34. United States Diabetic Lancets Market Share by Application in 2023 & 2030

Figure 35. United States Diabetic Lancets Sales in Value by Application (2019-2030) & (US$ Million)

Figure 36. United States Diabetic Lancets Sales Market Share in Value by Application (2019-2030)

Figure 37. United States Diabetic Lancets Sales by Application (2019-2030) & (K Units)

Figure 38. United States Diabetic Lancets Sales Market Share in Volume by Application (2019-2030)

Figure 39. United States Diabetic Lancets Price by Application (2019-2030) & (US$/Unit)

Figure 40. The Top 5 and 10 Largest Manufacturers of Diabetic Lancets in the World: Market Share by Diabetic Lancets Revenue in 2023

Figure 41. Global Diabetic Lancets Market Size Market Share by Region: 2019 VS 2023 VS 2030

Figure 42. Global Diabetic Lancets Sales in Volume Market Share by Region (2019-2030)

Figure 43. Global Diabetic Lancets Sales in Value Market Share by Region (2019-2030)

Figure 44. Americas Diabetic Lancets Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 45. Americas Diabetic Lancets Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 46. Americas Diabetic Lancets Sales by Type (2019-2030) & (K Units)

Figure 47. Americas Diabetic Lancets Sales Market Share in Volume by Type (2019-2030)

Figure 48. Americas Diabetic Lancets Sales by Application (2019-2030) & (K Units)

Figure 49. Americas Diabetic Lancets Sales Market Share in Volume by Application (2019-2030)

Figure 50. United States Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 51. Canada Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 52. Mexico Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 53. Brazil Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 54. EMEA Diabetic Lancets Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 55. EMEA Diabetic Lancets Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 56. EMEA Diabetic Lancets Sales by Type (2019-2030) & (K Units)

Figure 57. EMEA Diabetic Lancets Sales Market Share in Volume by Type (2019-2030)

Figure 58. EMEA Diabetic Lancets Sales by Application (2019-2030) & (K Units)

Figure 59. EMEA Diabetic Lancets Sales Market Share in Volume by Application (2019-2030)

Figure 60. Europe Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 61. Middle East Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 62. Africa Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 63. China Diabetic Lancets Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 64. China Diabetic Lancets Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 65. China Diabetic Lancets Sales by Type (2019-2030) & (K Units)

Figure 66. China Diabetic Lancets Sales Market Share in Volume by Type (2019-2030)

Figure 67. China Diabetic Lancets Sales by Application (2019-2030) & (K Units)

Figure 68. China Diabetic Lancets Sales Market Share in Volume by Application (2019-2030)

Figure 69. APAC Diabetic Lancets Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 70. APAC Diabetic Lancets Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 71. APAC Diabetic Lancets Sales by Type (2019-2030) & (K Units)

Figure 72. APAC Diabetic Lancets Sales Market Share in Volume by Type (2019-2030)

Figure 73. APAC Diabetic Lancets Sales by Application (2019-2030) & (K Units)

Figure 74. APAC Diabetic Lancets Sales Market Share in Volume by Application (2019-2030)

Figure 75. Japan Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 76. South Korea Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 77. China Taiwan Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 78. Southeast Asia Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 79. India Diabetic Lancets Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 80. Diabetic Lancets Value Chain

Figure 81. Diabetic Lancets Production Process

Figure 82. Channels of Distribution (Direct Vs Distribution)

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 4.3% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What is the annual compound growth rate of the global Diabetic Lancets market size from 2024 to 2030? shouQi

Which companies rank high in the global Diabetic Lancets market? shouQi

What was the global market size of Diabetic Lancets in 2030? shouQi

What was the global market size of Diabetic Lancets in 2024? shouQi

Related Reports

Global Diabetic Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Diabetic Lancets market is projected to grow from US$ 1247 million in 2025 to US$ 1664 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 179
USD 4900.00
(Single User License)
Global Diabetic Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetic Lancets market size was US$ 1247 million in 2025 and is forecast to reach a readjusted size of US$ 1664 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 108
USD 4250.00
(Single User License)
Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetic Lancets was estimated to be worth US$ 1247 million in 2025 and is projected to reach US$ 1664 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 132
USD 3950.00
(Single User License)
Global Diabetic Lancets Market Research Report 2026
The global Diabetic Lancets market was valued at US$ 1247 million in 2025 and is anticipated to reach US$ 1664 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 135
USD 2900.00
(Single User License)
Global Diabetic Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetic Lancets market is projected to grow from US$ 1201 million in 2024 to US$ 1603 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-23
Pages: 179
USD 4900.00
(Single User License)
Diabetic Lancets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetic Lancets was estimated to be worth US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-04-14
Pages: 149
USD 3950.00
(Single User License)
Global Diabetic Lancets Market Insights, Forecast to 2031
The global Diabetic Lancets market is projected to grow from US$ 1247 million in 2025 to US$ 1603 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Published Date: 2025-04-14
Pages: 180
USD 4900.00
(Single User License)
Global Diabetic Lancets Market Research Report 2025
The global market for Diabetic Lancets was valued at US$ 1201 million in the year 2024 and is projected to reach a revised size of US$ 1603 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-04-14
Pages: 107
USD 2900.00
(Single User License)
Global Diabetic Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetic Lancets market size was US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-04-14
Pages: 110
USD 4250.00
(Single User License)
Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetic Lancets was estimated to be worth US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-02-19
Pages: 131
USD 3950.00
(Single User License)

Global Diabetic Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Diabetic Lancets market is projected to grow from US$ 1247 million in 2025 to US$ 1664 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 179
USD 4900.00 (Single User License)
Global Diabetic Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetic Lancets market size was US$ 1247 million in 2025 and is forecast to reach a readjusted size of US$ 1664 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 108
USD 4250.00 (Single User License)
Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetic Lancets was estimated to be worth US$ 1247 million in 2025 and is projected to reach US$ 1664 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 132
USD 3950.00 (Single User License)
Global Diabetic Lancets Market Research Report 2026
The global Diabetic Lancets market was valued at US$ 1247 million in 2025 and is anticipated to reach US$ 1664 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 135
USD 2900.00 (Single User License)
Global Diabetic Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetic Lancets market is projected to grow from US$ 1201 million in 2024 to US$ 1603 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-23
Pages: 179
USD 4900.00 (Single User License)
Diabetic Lancets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetic Lancets was estimated to be worth US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-04-14
Pages: 149
USD 3950.00 (Single User License)
Global Diabetic Lancets Market Insights, Forecast to 2031
The global Diabetic Lancets market is projected to grow from US$ 1247 million in 2025 to US$ 1603 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Published: 2025-04-14
Pages: 180
USD 4900.00 (Single User License)
Global Diabetic Lancets Market Research Report 2025
The global market for Diabetic Lancets was valued at US$ 1201 million in the year 2024 and is projected to reach a revised size of US$ 1603 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-04-14
Pages: 107
USD 2900.00 (Single User License)
Global Diabetic Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetic Lancets market size was US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-04-14
Pages: 110
USD 4250.00 (Single User License)
Diabetic Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetic Lancets was estimated to be worth US$ 1201 million in 2024 and is forecast to a readjusted size of US$ 1603 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-02-19
Pages: 131
USD 3950.00 (Single User License)